50
Translational Clinical Research to the Community in the Case of Diabetes Prevention David G Marrero, Ph.D. J.O. Ritchey Professor of Medicine Director, Diabetes Translational Research Center Indiana University School of Medicine

Diabetes Prevention with Dr. David Marrero

Embed Size (px)

Citation preview

Page 1: Diabetes Prevention with Dr. David Marrero

Translational Clinical Researchto the Community in the Case

of Diabetes PreventionDavid G Marrero, Ph.D.J.O. Ritchey Professor of Medicine Director, Diabetes Translational Research CenterIndiana University School of Medicine

Page 2: Diabetes Prevention with Dr. David Marrero

THE PROBLEM

Page 3: Diabetes Prevention with Dr. David Marrero

The Problem of Diabetes is Growing….

Page 4: Diabetes Prevention with Dr. David Marrero
Page 5: Diabetes Prevention with Dr. David Marrero

Pre-diabetes: • 86 million Americans

• 35% of all adults• 50% of adults >65

• Progression to diabetes 5 – 15% per year

Diabetes in U.S. – Tip of the Iceberg

Diabetes – • 29 million Americans• 8.3% U.S. population

Page 6: Diabetes Prevention with Dr. David Marrero
Page 7: Diabetes Prevention with Dr. David Marrero

Why is this happening?

Page 8: Diabetes Prevention with Dr. David Marrero

Age-adjusted Prevalence of Obesity and Diagnosed Diabetes Among US Adults

Obesity (BMI ≥30 kg/m2)

Diabetes

1994

1994

2000

2000

No Data <14.0% 14.0%–17.9% 18.0%–21.9% 22.0%–25.9% > 26.0%

No Data <4.5% 4.5%–5.9% 6.0%–7.4% 7.5%–8.9% >9.0%CDC’s Division of Diabetes Translation. National Diabetes Surveillance System available at http://www.cdc.gov/diabetes/statistics

2013

2013

Page 9: Diabetes Prevention with Dr. David Marrero

Etiology of Obesity: Dietary IntakeDaily caloric intake increased dramatically in the past 30 years

- Increased portion sizesMarketplace portions are 2-

8 fold larger than FDA recommendations

- Increased frequency of eating out/fast food consumption

- Fast-food consumption has strong positive associations with weight gain and insulin resistance

Pereira MA et al. The Lancet. 365(9453):36-42

Page 10: Diabetes Prevention with Dr. David Marrero
Page 11: Diabetes Prevention with Dr. David Marrero
Page 12: Diabetes Prevention with Dr. David Marrero
Page 13: Diabetes Prevention with Dr. David Marrero
Page 14: Diabetes Prevention with Dr. David Marrero
Page 15: Diabetes Prevention with Dr. David Marrero

Building/Community Designs Discourage Walking

Page 16: Diabetes Prevention with Dr. David Marrero
Page 17: Diabetes Prevention with Dr. David Marrero
Page 18: Diabetes Prevention with Dr. David Marrero
Page 19: Diabetes Prevention with Dr. David Marrero

WHAT CAN WE DO ABOUT IT?

Page 20: Diabetes Prevention with Dr. David Marrero

The Diabetes Prevention Program

Page 21: Diabetes Prevention with Dr. David Marrero

Diabetes Prevention – the DPP

3-arm nation-wide RCT with >3,000 participants with pre-diabetes (IGT) Intensive Lifestyle Intervention Metformin (Diabetes medication) Placebo (Basic advice)

Page 22: Diabetes Prevention with Dr. David Marrero

Development of Diabetes

Placebo Metformin Life-style

Development of diabetes 11.0% 7.8% 4.8% (percent per year)

Reduction of diabetes ---- 31% 58% compared with placebo

Number needed to treat ---- 13.9 6.9

to prevent 1 case in 3 yrs

Page 23: Diabetes Prevention with Dr. David Marrero

All ethnic/racial groups Men and women, lean, plump or fat All adults, especially those over age 60

DPP Lifestyle Intervention Worked for:

Page 24: Diabetes Prevention with Dr. David Marrero

SO WHY DON’T HE HAVE A DIABETES PREVENTION PROGRAM ON EVERY STREET CORNER?

Page 25: Diabetes Prevention with Dr. David Marrero

DPP Translation: Efficacy vs. Public HealthPopulation-

Level Diabetes

Prevention

Evidence-base

Real-World Implementati

on

Linked to healthcareFeasible across settingsScalable nationally

Worth the investment

Health PayersEmployersIndividuals

Minimize Costs : Optimize Effectiveness

Page 26: Diabetes Prevention with Dr. David Marrero

Barriers to “DPP for All” Evidence only supports Pre-Diabetes

Requires a blood test Not a routine in primary care settings Not well understood by public

Need for Scalable Models Purchaser must believe a program has fidelity Programs must be widely available (meet demand) Must be cost effective

What do we translate?

Page 27: Diabetes Prevention with Dr. David Marrero

Goals for DPP Translation Maintain fidelity to “core” evidence

Paying for intensive lifestyle interventions is a value for the dollar in adults with PRE-DIABETES

We don’t know if other strategies are cost effective Less intensive interventions Targeting lower risk groups (e.g. all obesity)

Adopt “practical” solutions for barriers Seek to demonstrate possible cost savings

Minimize intervention costs Preserve effectiveness (weight maintenance)

Page 28: Diabetes Prevention with Dr. David Marrero

Developing a Scalable Model

Simplify testing Lower intervention costs Partner with community to share

resources

Page 29: Diabetes Prevention with Dr. David Marrero

Partnered Approach for Prevention

Healthcare

Glucose testingRisk/benefit assessment (safe?)Prescriptive advice (role for meds?)Gateway to reimbursement

Formal Programs

CommunityPopulation Resources

EnvironmentEducation by Schools &

Media Lower intensity

programsRisk assessment

opportunities

Reciprocal Interactions

PersonnelExperienceFacilitiesContact

Page 30: Diabetes Prevention with Dr. David Marrero

A FEW EXAMPLES FROM OUR CENTER…

Page 31: Diabetes Prevention with Dr. David Marrero

P L

Diabetes Education & Prevention with a Lifestyle Intervention Offered at the

YMCA

D E O Y

Page 32: Diabetes Prevention with Dr. David Marrero

Why the Y? Lower Cost Programs

Lower cost “lay” group leaders Operate to achieve cost recovery only Policy to turn no person away for inability to

pay

Past experience with national program scaling

Page 33: Diabetes Prevention with Dr. David Marrero

Availability and Penetration• 2700 Y

facilities

• 57% of U.S. households are located within 3 miles of a YMCA

Page 34: Diabetes Prevention with Dr. David Marrero

DPP Lifestyle Intervention Delivered in the YMCA

Group randomized pilot comparative effectiveness trial Participants (N = 94)

Overweight/obese High random capillary glucose + T2DM risk factors* Allocated based on YMCA site for screening

Intervention – Offered group-based DPP Control – Given basic advice & other Y programs

Can the YMCA deliver group-based DPP? Could it achieve similar weight loss to DPP? Would it be less costly?

Ackermann, et al. Am J Prev Med. 2008 Oct;35(4):357-63;

Page 35: Diabetes Prevention with Dr. David Marrero

Results: Weight Loss & Maintenance

6 months 12 months 20 months 28 months0%1%2%3%4%5%6%7%8%9%

10%

p<0.001 p=0.008

Brief AdviceYMCA Group DPP

Perc

ent W

eigh

t Los

s

P=0.003P=0.003

*p-values comparing Group DPP to Brief Advice

Ackermann, et al. Am J Prev Med. 2008 Oct;35(4):357-63;

Same intervention now offered to both

groups

Page 36: Diabetes Prevention with Dr. David Marrero

DEPLOY Cholesterol & Maintenance

-25%

-20%

-15%

-10%

-5%

0%

5%

10%

p<0.001

P<0.002Perc

ent C

hang

e

6 month 12 month 24 month 32 month

*p-values comparing Group DPP to Brief AdviceAckermann, et al. Am J Prev Med. 2008 Oct;35(4):357-63

P=0.52

P=0.003

Page 37: Diabetes Prevention with Dr. David Marrero

Minimizing Program Costs

Cost CategoryOriginal

DPP No IncentivesGroup Format

Group Format –

YMCA Instructor

Personnel $794 $794 $156 $151

Supplies $11 $11 $11 $10

Incentives $123 $10 $10 $10

Overhead $548 $548 $108 $34

Total $1,476 $1,363 $284 $205

Page 38: Diabetes Prevention with Dr. David Marrero

WHERE DID THIS WORK GO?

Page 39: Diabetes Prevention with Dr. David Marrero

The National YMCA DPP

Decision to ramp up DEPLOY to YMCAs across the country Standardize training Standardize program elements and adapt

to Y culture.

Page 40: Diabetes Prevention with Dr. David Marrero

The National Diabetes Prevention Program

2011: Congressional legislation established the CDC-led National Diabetes Prevention Program

Establish local evidence-based lifestyle change programs for people at high risk for type 2 diabetes Train workforce to implement cost effectively Recognition Program: Assure quality and (hopefully) lead

to reimbursement Develop intervention sites Marketing to support program uptake

Inaugural partners (YMCA and United Health Group)

Already provided services to thousands of patients

Page 41: Diabetes Prevention with Dr. David Marrero

Getting it covered as a Benefit: The United Health Group Project

Collaboration between the YMCA and UHG First payer to cover the benefit for persons

identified as high risk by providers and referred to YDPP sites

Scaled payment based on performance

Page 42: Diabetes Prevention with Dr. David Marrero

THE YDPP AND THE NDPP ARE GOOD STARTS, BUT STILL FALL FAR SHORT OF THE

SCALE WE NEED TO COMBAT THIS EPIDEMIC.

WHERE CAN WE GO NEXT? HOW CAN WE EXPAND REACH AND ACCESS?

Page 43: Diabetes Prevention with Dr. David Marrero

CAN A COMMERCIAL PROGRAM PROVIDE AN ALTERNATIVE APPROACH?

Page 44: Diabetes Prevention with Dr. David Marrero

Weight Watchers Leading global provider of weight

management services

Teach people to lose weight and keep it off by adopting a healthier lifestyle

Clinically proven lifestyle program promotes healthy habits, a supportive environment, exercise, and smarter food choices 44

Page 45: Diabetes Prevention with Dr. David Marrero

Weight Watchers Reach – U.S. Annually more than 1.7 million enrollments in Weight

Watchers meetings and 1 million signups for WeightWatchers.com

25,000 meetings each week held in convenient times and locations (~5,000 in workplace)

75% of members live with a 12 minute drive to a meeting

Open attendance – no need to reserve or schedule ahead of time

25,000 field staff, all of whom are Lifetime Members LTMs attend meetings for free as a reward when

maintaining their weight goal45

Page 46: Diabetes Prevention with Dr. David Marrero
Page 47: Diabetes Prevention with Dr. David Marrero

The Study RCT with 250 subjects with diagnosed IGT

Wait list control Comparison of WW with the same self help

program used in DEPLOY Data collected at 6, 12, and 24 months At 6 months, 5.7% weight loss vs. 1% in

controls. At 12 months, 5.8% vs. 2%

Page 48: Diabetes Prevention with Dr. David Marrero

The Public Health Promise Weight Watchers is the only at-scale provider of education

behavior modification for weight management in the world, and the only potential DPP partner with

Brand awareness, channel access and investment to drive demand for Diabetes Prevention Programs

Infrastructure to fulfill demand at scale quickly Experience with recruitment, training and

management to deliver consistent, high quality results A built-in base of role model service providers A science-based approach that mirrors that of the DPP

48

Page 49: Diabetes Prevention with Dr. David Marrero

The Encourage Study: targeting kids Introduction of “primordial” prevention Targeting mothers with GDM and their

children Two group RCT:

Moms only Moms plus kids in parallel programs

Page 50: Diabetes Prevention with Dr. David Marrero